---
title: "Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299174691.md"
description: "In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Bristol-Myers Squibb, with a price target of $82.00. According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.0% and a 59.92% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as AbbVie, Teva Pharmaceutical, and Amgen. Currently, the analyst consensus on Bristol-Myers Squibb is a Moderate Buy with an average price target of $67.22."
datetime: "2026-09-16T11:16:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299174691.md)
  - [en](https://longbridge.com/en/news/299174691.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299174691.md)
generator: "portal-rs"
---

# Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler

In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Bristol-Myers Squibb, with a price target of $82.00.

According to TipRanks, Amsellem is a 5-star analyst with an average return of 15.0% and a 59.92% success rate. Amsellem covers the Healthcare sector, focusing on stocks such as AbbVie, Teva Pharmaceutical, and Amgen.

Currently, the analyst consensus on Bristol-Myers Squibb is a Moderate Buy with an average price target of $67.22.

### Related Stocks

- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [TEVA.US](https://longbridge.com/en/quote/TEVA.US.md)
- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md)

## Related News & Research

- [Bristol Myers Swoons on Test Results](https://longbridge.com/en/news/298335284.md)
- [BMS reports positive data from Phase II QUINTESSENTIAL study for r/r MM](https://longbridge.com/en/news/298442546.md)
- [CoreWeave Just Got a Big Vote of Confidence But There's a Catch](https://longbridge.com/en/news/299923059.md)
- [McDonald's Stock Price Forecast: MCD Tumbles to 2022 Low, Will It Fall Further or Rebound?](https://longbridge.com/en/news/299996327.md)
- [Prediction: A $1,000 Investment in Nebius Stock Will Be Worth This Much in 2028 (Hint: It Implies a Big Jump)](https://longbridge.com/en/news/300026118.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**